Stereotaxis, Inc.
NYSE: STXSElectromedical & Electrotherapeutic Apparatus · Entity-resolved by Clous
CIK0001289340
TickerSTXS
ExchangeNYSE
SIC3845
StateDE
FY end12-31
Key financials
RevenueFY2025-12-31
$32.38M
+20.3% YoY
Net IncomeFY2025-12-31
-$21.64M
+10.0% YoY
Total AssetsFY2025-12-31
$52.25M
+11.8% YoY
EquityFY2025-12-31
$13.48M
+121.7% YoY
Shares OutstandingFY2025-12-31
97.25M
—
Operating Cash FlowFY2025-12-31
-$13.69M
-61.1% YoY
AI business summary — latest 10-K
Summary
Stereotaxis filed Amendment No.1 to its 2025 Form 10-K to add the missing Ernst & Young audit signature and correct an exhibit number mis‑labeling.
What it means
The filing fixes a clerical error; no new financial information or material changes are disclosed.
What to watch
Monitor future filings for any substantive amendments or restatements.
Generated from public filings · not investment advice
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | $28.15M | $26.77M | $26.92M | $32.38M | +20.3% | 100% |
| Net Income | -$18.29M | -$20.71M | -$24.05M | -$21.64M | +10.0% | -67% |
| Total Assets | $53.41M | $41.91M | $46.72M | $52.25M | +11.8% | 161% |
| Equity | $26.35M | $16.34M | $6.08M | $13.48M | +121.7% | 42% |
| Operating Cash Flow | -$8.42M | -$9.14M | -$8.5M | -$13.69M | -61.1% | -42% |
| Shares Outstanding | — | — | — | 97.25M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001289340